ESC - European Society of Cardiology
ESC - European Society of Cardiology
08/30/2024 | Press release | Distributed by Public on 08/30/2024 04:40
Is long term beta blocker therapy needed after a heart attack
Notes to editor
This press release accompanies both a presentation and an ESC press conference at ESC Congress 2024. It does not necessarily reflect the opinion of the European Society of Cardiology.
ESC Press Office
Tel: +33 (0)6 61 40 18 84
Email: [email protected]
The hashtag for ESC Congress 2024 is #ESCCongress
Follow us on X @ESCardioNews
Journalists are invited to become accredited and register here.
Check out the ESC Media and Embargo Policy.
Funding: The study was funded by the French Ministry of Health (PHRC-2015) and the ACTION Study Group (www.action-groupe.org).
Disclosures: Johanne Silvain declares the following during the last 2 years: consulting fees or lecture fees from BIOTRONIK FRANCE SAS; SANOFI AVENTIS FRANCE, CSL BEHRING S.A.; travel support/hospitality from ABBOTT MEDICAL FRANCE SAS, BIOTRONIK FRANCE SAS, MEDTRONIC INTERNATIONAL TRADING SARL, NOVO NORDISK; stockholder with 4P-PHARMA.
References and notes
1'Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control' will be discussed during Hot Line 1 on Friday 30 August in room London.
2Holt A, Blanche P, Zareini B, et al. Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study. Eur Heart J. 2021;42:907-914.
3Park CS, Yang H-M, Ki Y-J, et al. Left ventricular ejection fraction 1 year after acute myocardial infarction identifies the benefits of the long-term use of beta-blockers: analysis of data from the KAMIR-NIH Registry. Circ Cardiovasc Interv. 2021;14:e010159.
4Puymirat E, Riant E, Aissaoui N, et al. β Blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study. BMJ. 2016;354:i4801.
5Kim J, Kang D, Park H, et al. Long-term β-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study. Eur Heart J. 2020;41:3521-3529.
6Yndigegn T, Lindahl B, Mars K, et al. Beta-blockers after myocardial infarction and preserved ejection fraction. N Engl J Med. 2024;390:1372-1381.
It is the world's largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in London and online - from 30 August to 2 September. Explore the scientific programme. More information is available from the ESC Press Office at [email protected].
About the European Society of Cardiology
The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.